Results 311 to 320 of about 843,078 (353)
Some of the next articles are maybe not open access.

Breast Metastasis from Non-Small-Cell Lung Carcinoma

Medical Oncology, 2003
Development of metastasis to the breast from lung cancer is very rare and the prognosis for such patients is poor. We present a patient who had metastasis to breast from non-small-cell lung cancer. It is important to distinguish a primary breast cancer from metastasis to the breast, as the therapy offered would be markedly different, with considerably ...
Kannan, Ramar   +3 more
openaire   +2 more sources

Treatment of Non-small Cell Lung Carcinoma in Early Stages

Cirugía Española (English Edition), 2013
Treatment of lung carcinoma is multidisciplinary. There are different therapeutic strategies available, although surgery shows the best results in those patients with lung carcinoma in early stages. Other options such as stereotactic radiation therapy are relegated to patients with small tumors and poor cardiopulmonary reserve or to those who reject ...
José Carlos, Meneses   +5 more
openaire   +2 more sources

TRIM3 facilitates ferroptosis in non-small cell lung cancer through promoting SLC7A11/xCT K11-linked ubiquitination and degradation

Cell Death and Differentiation, 2023
Zhangjie Wang   +8 more
semanticscholar   +1 more source

Non–Small Cell Lung Carcinoma

Pathology Case Reviews, 2009
Michael O. Idowu   +2 more
openaire   +1 more source

Phase I trial of the HDAC inhibitor LBH589 in combination with sorafenib in patients with renal cell carcinoma, non-small cell lung cancer and soft tissue sarcomas.

Journal of Clinical Oncology, 2012
C. Butler   +5 more
semanticscholar   +1 more source

Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.

International Journal of Radiation Oncology, Biology, Physics, 2017
Linda C. Chen   +13 more
semanticscholar   +1 more source

Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions

Ca-A Cancer Journal for Clinicians, 2023
Zsolt Megyesfalvi   +2 more
exaly  

[Diagnostics of non-small cell lung carcinoma].

Duodecim; laaketieteellinen aikakauskirja, 2014
ALK inhibitor therapy is individual cancer treatment, in which the targeted drug therapy is directed to a patient group that is likely to benefit from the therapy. The detection in the tumor of ALK gene (anaplastic lymphoma kinase) rearrangement is a prerequisite for the ALK inhibitor therapy for non-small cell lung carcinoma.
Kaisa, Salmenkivi, Aija, Knuuttila
openaire   +1 more source

Immune-checkpoint inhibition for resectable non-small-cell lung cancer — opportunities and challenges

Nature Reviews Clinical Oncology, 2023
Giannis Mountzios   +2 more
exaly  

Home - About - Disclaimer - Privacy